Cargando…
Clinical consequences of a genetic predisposition toward higher benign prostate-specific antigen levels
BACKGROUND: Prostate-specific antigen (PSA) levels are influenced by genetic variation unrelated to prostate cancer risk. Whether a genetic predisposition to a higher PSA level predisposes to a diagnostic work-up for prostate cancer is not known. METHODS: Participants were 3110 men of African and Eu...
Autores principales: | Shi, Mingjian, Shelley, John P., Schaffer, Kerry R., Tosoian, Jeffrey J., Bagheri, Minoo, Witte, John S., Kachuri, Linda, Mosley, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597757/ https://www.ncbi.nlm.nih.gov/pubmed/37865044 http://dx.doi.org/10.1016/j.ebiom.2023.104838 |
Ejemplares similares
-
Clinical consequences of a polygenic predisposition to benign lower white blood cell counts: Consequences of benign WBC count genetics
por: Mosley, Jonathan D., et al.
Publicado: (2023) -
Transcriptome-Wide Association Analysis Identifies Novel Candidate Susceptibility Genes for Prostate-Specific Antigen Levels in Men Without Prostate Cancer
por: Chen, Dorothy M., et al.
Publicado: (2023) -
Genetically adjusted PSA levels for prostate cancer screening
por: Kachuri, Linda, et al.
Publicado: (2023) -
Genotype-based “virtual” metabolomics in a clinical biobank identifies novel metabolite-disease associations
por: Bagheri, Minoo, et al.
Publicado: (2023) -
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)